NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Pavlosvr and Evaluate,

Thanks! I agree.
I sent an email to Allison Joost this morning:

Dear Allison Joost,

I have a question in regards to Abstract/Poster Presentation 787 (Phase III Clinical Trial to Test the Safety and Efficacy of Autologous Tumor Lysate-Loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma).

1. Will Late-Breaking Abstract 787 be released Monday, Nov. 9 at 8 a.m. EST or is LB Abstract 787 withdrawn per Authors?

2.The authors shown are: Marnix L. Bosch, MBA, PhD; Linda Liau; Keyoumars Ashkan.

If there is an oral presentation: would this be via Zoom presentation?

Are all 3 of above authors available during the presentation or Q&A?

I just got this reply:

Hi XXXX,

Thank you for reaching out. Abstract 787 will be released on Monday, Nov. 9 at 8 a.m. EST as part of the JITC Supplement. As for your second question, this abstract was offered a poster presentation in our virtual poster hall. However, the authors have not submitted a poster yet, and if there is not a submitted poster, it will not be displayed in the virtual poster hall. If a poster is submitted, the presenting author does have the option to record audio with the poster, as well as be available during specific ePoster Viewing Sessions where attendees can interact with them.



Please let me know if you have any other questions.



Thank you,

Allison Joost

Senior Program Manager, SITC